Reboundweightgainafter semaglutide The efficacy of semaglutide in facilitating significant weight loss is well-documented through numerous clinical trials. However, a crucial aspect that garners considerable attention is the phenomenon of weight regain after discontinuing such treatments. This article delves into the complexities of weight regain after stopping semaglutide trial participation, exploring the rates, contributing factors, and the long-term implications for individuals.
Research consistently indicates that weight regain is a common outcome following the cessation of semaglutide and other GLP-1 receptor agonists.2025年8月8日—Weight regainvaried with follow-up, with study participants experiencing significant periods ofweight regainat eight, 12, and 20 weeksafter... A meta-regression analysis highlights that participants regain approximately 60% of the weight they lost during treatment within one year of stopping the medication. This trend is further supported by findings that participants treated with weight loss drugs regained on average 0作者:H Wu·2025·被引用次数:7—During the follow-up period,significant weight regain was observed from 8 to 52 weeksafter treatment discontinuation (Figs. 4 and 5). Fig. 4..4 kg/month after cessation. Some studies report even higher rates, with analyses of pooled trial data revealing an average monthly rate of weight regain was 0.4kg. Specifically, in a notable trial, it was observed that participants regained a mean of two-thirds of their prior weight loss within a year of withdrawing from semaglutide and a structured lifestyle intervention.2026年1月7日—Participants treated with weight-loss drugs regained on average 0.4 kg/monthafter stopping treatment, regaining, on average, 4.8 kilograms or ... In some instances, this weight regain can be rapid, with studies indicating a comparative rapidity following semaglutide withdrawal.
The rate at which weight regain occurs can varyDoes Stopping Ozempic Cause Rebound Weight Gain and .... For instance, while some analyses suggest an average monthly regain of 0.4 kg, specific cohorts might experience different trajectories. In longer trials with follow-up periods exceeding 26 weeks, greater weight regain has been observed compared to shorter trials. One study indicated that following treatment withdrawal, semaglutide and placebo participants regained 11.6 (SD: 7.7) and 1.New study finds that stopping weight-loss drugs is linked to ...9 (SD: 4.8) percentage points of lost weight by week 120, suggesting a significant rebound effect associated with the active medication. Furthermore, the overall average weight regained across all treatments was 4.2024年5月11日—46 out of 240 patients restarted semaglutide after stopping.Average weight gain from cessation to restarting the drug was 1.3%. The researchers ...8 kg in the first year, with projections indicating a return to baseline weight within 12024年1月23日—However, a portion of patients whostoptaking either medication experienceweight regain, with 18.7% of liraglutide users and 17.7% ofsemaglutideusers regaining all the weight they had lost or more. In a previous study, we demonstrated that patients using the recommended weight loss dose of ....5 to 1.7 years for those who previously took semaglutide and tirzepatide.
It is crucial to understand that the discontinuation of semaglutide often leads to a reversal of the beneficial effects observed during treatment, not only concerning weight but also cardiometabolic healthWeight Regain Faster After Stopping Meds Than .... The consensus from various studies, including those examining newer medicines like semaglutide and tirzepatide, suggests that the regain of weight is a primary concern. For these newer agents, regain averaged 0.2026年1月7日—People whostoptakingweight-loss drugs tend toregaintheweightthey lost within less than two years, according to a study of more than 9000 ...8 kg (~1.8 pounds) per month, with predictions pointing towards a return to previous weight levels. One study in 2022 found that participants had regained about two-thirds of their prior weight loss approximately a year after ceasing a GLP-1. Moreover, a concerning statistic reveals that 17.7% of semaglutide users experienced regaining all the weight they had lost or more.
The underlying mechanisms contributing to this weight regain are complex and multifactorialIs coming off semaglutide slowly the key to preventing .... Semaglutide, as a GLP-1 receptor agonist, influences appetite and satiety.New study finds that stopping weight-loss drugs is linked to ... When the drug is stopped, these regulatory pathways may revert, leading to increased hunger and reduced feelings of fullness. This often means that the weight regain is much faster than [after stopping] diets. The concept of "metabolic rebound" after GLP-1 receptor agonist discontinuation is also being explored, suggesting physiological adaptations that promote weight accumulation.
For individuals participating in semaglutide trials, understanding these outcomes is vital for managing expectations and planning long-term strategiesWeight regain and cardiometabolic effects after withdrawal .... While the initial goal of trial participation might be weight loss, the sustained management of weight post-treatment requires continued effort. The significant weight loss achieved during trials can be substantial, and the subsequent weight regain can be disheartening if not anticipated作者:CC Tzang·2025—Trialswith follow-ups of >26 weeks showed greaterweight regain(7.31 kg) compared to those with ≤26 weeks (2.51 kg; p = 0.007). Similar patterns were observed .... For example, in the STEP 1 extension trial, participants regained an average of two-thirds of the weight they shed within 12 months. Another observation from the SURMOUNT-4 trial indicated that most adults with obesity who had tirzepatide withdrawn following a 36-week treatment regained weightDoes Stopping Ozempic Cause Rebound Weight Gain and ....
In conclusion, weight regain after stopping semaglutide trial participation is a well-established phenomenon. The observed rates, often around 0.4kg/month or two-thirds of prior weight loss within a year, underscore the chronic nature of obesity and the potential need for ongoing management strategies. While semaglutide offers a powerful tool for weight reduction, long-term success hinges on continued lifestyle interventions and potentially further therapeutic considerations to mitigate the effects of following drug discontinuation. It is imperative for healthcare providers and patients to engage in open discussions about these outcomes to ensure comprehensive and sustainable health management.Weight regain after stopping Semaglutide: In the STEP 1 extension trial, patients from the STEP 1 trial (68 weeks of treatment with semaglutide 2.4mg weekly) ...
Join the newsletter to receive news, updates, new products and freebies in your inbox.